Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Arm Open-Label Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

NCT06257355 is registered in ClinicalTrials.gov with Claris Biotherapeutics, Inc. as lead sponsor.

NCT NCT06257355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Arm Open-Label Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
Lead sponsor
Claris Biotherapeutics, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
February 5, 2024
Completion date
June 30, 2027
Enrollment
20 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

corneal scar